US FDA CBER Chief Calls For Industry-Academia Collaboration In Developing Treatments For Ultra-Rare Diseases

 
• By Joanne S. Eglovitch
  
Genetic Medicine with dna isolated on white.3d rendering
US FDA's Marks: Industry and academia could collaborate to treat the rarest of diseases
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America